Video on
msnbc.com: Gilead
Sciences reported
Q2 EPS of $2.36
ex-items on
revenue of $6.53
billion, with
$3.48 billion
sales of Sovaldi.
CNBC's Me
(more)
Video on msnbc.com: Gilead Sciences reported Q2 EPS of $2.36 ex-items on revenue of $6.53 billion, with $3.48 billion sales of Sovaldi. CNBC's Meg Tirrell reports the highlights from the conference call.